Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Greenbrook Tms Inc GBNHF

Healthcare
Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS) therapy and Spravato (esketamine nasal spray) therapy in the United States for the treatment of depressive disorder (MDD) and other mental health disorders. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Spravato is offered to treat... see more

Recent & Breaking News (OTCQB:GBNHF)

IIROC Trading Halt - GTMS

Canada NewsWire September 11, 2019

Greenbrook TMS to Acquire Achieve TMS

Business Wire September 11, 2019

Greenbrook TMS Continues Execution of Growth Strategy and Reports Record Second Quarter Financial Results

Business Wire August 6, 2019

Greenbrook TMS Announces Dates for Its Second Quarter 2019 Financial Results

Business Wire July 9, 2019

Greenbrook TMS Announces Results of Voting at Annual and Special Meeting of Shareholders

Business Wire June 28, 2019

Greenbrook TMS Completes C$30 Million Bought Deal Public Offering and Concurrent Private Placement

Business Wire May 17, 2019

Greenbrook TMS Continues Execution of Growth Strategy and Reports First Quarter Financial Results

Business Wire May 9, 2019

Greenbrook TMS Announces Expansion into Michigan

Business Wire May 9, 2019

Greenbrook TMS Announces C$29 Million Bought Deal Public Offering and Concurrent Private Placement

Business Wire April 29, 2019

Greenbrook TMS Announces C$29 Million Bought Deal Public Offering and Concurrent Private Placement

Press Releases April 29, 2019

Greenbrook TMS to Present at 2019 Bloom Burton & Co. Healthcare Investor Conference

Press Releases April 18, 2019

Greenbrook TMS to Present at 2019 Bloom Burton & Co. Healthcare Investor Conference

Business Wire April 18, 2019

Greenbrook TMS Selected by Kaiser Permanente as Provider of TMS Therapy Services in the Mid-Atlantic States

Business Wire April 2, 2019

Greenbrook TMS Reports Fourth Quarter and Year End 2018 Financial Results

Business Wire March 27, 2019

Greenbrook TMS Announces Dates for Its Fourth Quarter and Year End 2018 Financial Results

Business Wire February 26, 2019

Greenbrook Tms Announces Expansion Into Tampa-St. Petersburg Florida

GlobeNewswire January 9, 2019

Greenbrook TMS Announces Expansion Into Cleveland, Ohio

GlobeNewswire December 28, 2018

Greenbrook TMS Continues Successful Execution of Growth Strategy and Reports Third Quarter Financial Results

Business Wire November 12, 2018

Greenbrook TMS Centers Begin to Treat Obsessive Compulsive Disorder With TMS Therapy

GlobeNewswire November 8, 2018

Greenbrook TMS Announces Expansion Into Houston Texas

GlobeNewswire October 31, 2018